We found that the C129S mutation in Ptpn22 leads to reduced catalytic activity and increased susceptibility to oxidative inactivation in vitro, causing concomitant upregulation of T cell activation and T-cell-mediated autoimmunity in a NOX2-dependent manner. The gene discussed is PTPN22; the disease is Autoimmunity.